4.14

0.48% -0.02

After Hours: 4.11 -0.03 -0.72%

Ataibeckley Inc (ATAI)

Overview News Price History Option Chain Financials Discussions Forecast

Ataibeckley Inc stock is traded at $4.14, with a volume of 2.35M. It is down -0.48% in the last 24 hours and up +11.89% over the past month. AtaiBeckley Inc is a clinical-stage biopharmaceutical company on a mission to transform patient outcomes by developing effective, rapid-acting, and convenient mental health treatments. AtaiBeckley's pipeline of novel therapies includes BPL-003 (mebufotenin benzoate nasal spray) for treatment-resistant depression (TRD), VLS-01 (DMT buccal film) for TRD, and EMP-01 ((R)-MDMA HCI) for social anxiety disorder, which are in Phase 2 clinical development.

Previous Close:

$4.16

Open:

$4.15

24h Volume:

2.35M

Relative Volume:

0.43

Market Cap:

$1.52B

Revenue:

$4.09M

Net Income/Loss:

$-660.15M

P/E Ratio:

-1.7959

EPS:

-2.3053

Net Cash Flow:

$-117.10M

1W Performance:

-10.58%

1M Performance:

+11.89%

6M Performance:

-29.11%

1Y Performance:

+181.63%

1-Day Range:

$4.085

$4.195

1-Week Range:

$4.01

$4.75

52-Week Range:

$1.29

$6.75

Ataibeckley Inc Stock (ATAI) Company Profile

Name

Ataibeckley Inc

Sector

Healthcare (1113)

Industry

Biotechnology (622)

Phone

1 929 207 2670

Address

C/O ATAI LIFE SCIENCES US, INC., NEW YORK

Employee

Twitter

Next Earnings Date

2026-05-13

Latest SEC Filings

ATAI's Discussions on Twitter

Compare ATAI vs VRTX, REGN, ARGX, ALNY, ONC

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
ATAI Ataibeckley Inc	4.14	1.53B	4.09M	-660.15M	-117.10M	-2.3053
VRTX Vertex Pharmaceuticals Inc	423.92	108.71B	12.07B	3.95B	3.19B	15.33
REGN Regeneron Pharmaceuticals Inc	701.42	74.13B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	783.50	48.61B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	296.11	41.29B	3.71B	313.75M	465.38M	2.2571
ONC Beone Medicines Ltd Adr	293.86	32.81B	5.36B	287.73M	924.18M	2.5229

Ataibeckley Inc Stock (ATAI) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Mar-27-26	Initiated	Deutsche Bank	Buy
Jan-20-26	Initiated	Guggenheim	Buy
Oct-13-25	Initiated	Needham	Buy
Jul-29-25	Initiated	Oppenheimer	Outperform
Nov-18-24	Reiterated	H.C. Wainwright	Buy
Apr-03-24	Upgrade	Maxim Group	Hold → Buy
Nov-01-22	Initiated	Loop Capital	Buy
Nov-30-21	Initiated	Maxim Group	Buy
Nov-11-21	Initiated	ROTH Capital	Buy
Oct-18-21	Initiated	H.C. Wainwright	Buy
Sep-01-21	Initiated	Jefferies	Buy
Jul-13-21	Initiated	Berenberg	Buy
Jul-13-21	Initiated	Canaccord Genuity	Buy
Jul-13-21	Initiated	Cantor Fitzgerald	Buy
Jul-13-21	Initiated	Citigroup	Buy
Jul-13-21	Initiated	Cowen	Outperform
Jul-13-21	Initiated	Credit Suisse	Outperform
Jul-13-21	Initiated	RBC Capital Mkts	Sector Perform
Jul-08-21	Initiated	Aegis Capital	Buy

View All

Ataibeckley Inc Stock (ATAI) Latest News

01:35 AM

10 Health Care Stocks With Whale Alerts In Today's Session - Benzinga

01:35 AM

11:19 AM

Does AtaiBeckley’s (ATAI) EMP-01 Data Hint At A Scalable MDMA Therapy Platform? - Yahoo Finance

11:19 AM

03:14 AM

Ataibeckley: Anxiety drug cuts social phobia symptoms by 38% - MSN

03:14 AM

Apr 30, 2026

These stocks are today’s movers: Fermi, AST SpaceMobile, Intel, Marvell, USA Rare Earth, Ataibeckley, and more - MSN

Apr 30, 2026

ATAI stock soars on track for best day on Trump psychedelics push and Wall Street cheers - MSN

Apr 30, 2026

Apr 29, 2026

Why Ataibeckley stock surged today - MSN

Apr 29, 2026

Atai Beckley N.V. (ATAI) Receives a Buy from H.C. Wainwright - The Globe and Mail

Apr 29, 2026

AtaiBeckley weighing options for lead psychedelic therapy: Bloomberg - MSN

Apr 29, 2026

Apr 28, 2026

Shroom stocks rise as Trump is said to sign executive order on psychedelic drug - MSN

Apr 28, 2026

Apr 27, 2026

Psychedelic stocks soar as Trump signs order to ease access - MSN

Apr 27, 2026

Small cap wrap: VivoPower, First Phosphate, ataiBeckley, Trillion Energy... - Proactive financial news

Apr 27, 2026

AtaiBeckley wins OVID Health Silver Award for patient partnership in psychedelic trials - Proactive Investors

Apr 27, 2026

Cybin stands out as the most undervalued psychedelic stock as Trump signs on faster PTSD research - MSN

Apr 27, 2026

AtaiBeckley and PsyPAN Receive a Silver Award in 2026 Patient Participant Index, Reflecting Ongoing Commitment to Participant-Informed Research - Investing News Network

Apr 27, 2026

AtaiBeckley and PsyPAN win silver for trial participant input - Stock Titan

Apr 27, 2026

Apr 26, 2026

Enveric Biosciences surges over 90%, other psychedelic stocks soar in Monday pre-market: What's going on? - MSN

Apr 26, 2026

AtaiBeckley Inc.Common Stock (NQ: ATAI - The Chronicle-Journal

Apr 26, 2026

Apr 25, 2026

AtaiBeckley’s EMP-01 Data Strengthen Case For Psychedelic Anxiety Pipeline - Sahm

Apr 25, 2026

Apr 24, 2026

ATAI Stock Soars On Track For Best Day On Trump Psychedelics Push And Wall Street Cheers - Stocktwits

Apr 24, 2026

Apr 23, 2026

Atai Beckley (ATAI): The Best Penny Stock to Buy and Hold Under $5 - Insider Monkey

Apr 23, 2026

Apr 22, 2026

ATAI (AtaiBeckley Inc.) beats fourth quarter 2025 EPS estimates, posts massive revenue growth, shares rise 2.25 percent.NCAV - Cổng thông tin điện tử tỉnh Tây Ninh

Apr 22, 2026